Search Result

All Related Services Other Content

Industry Shift: FDA Goes Vegan? Approaching Drug Development With FinesseIn 2012, drug development specialists started an initiative to create predictive Oral Bioavailability Tools (OrBiTo). This initiative recognized the need to mo...
Animal Dosing Vehicle Selection Choosing an optimal vehicle for animal PK and Tox studies requires multidisciplinary skillsets and a sound understanding of the physicochemical properties of your compound. Controlling solid and solut...
Analytical Research and Quality Control We will provide our valued customers with analytical chemistry research and quality control services for NCEs throughout their life cycle from the early clinical stage to commercial manufacturing. Ana...
ASD Series
Development and Production Application Cases of Amorphous Solid Dispersion Formulations (I) - Hot Melt Extrusion Hot-melt extrusion (HME) is recognized as an optimal and efficient technique for manufacturing amorphous solid dispersions, characterized by its continuous processing, increased production efficiency,...
Overcoming Bioavailability Barrier to Deliver Protein Degraders Speaker: Dr. Chong-Hui Gu, Head of CMC and QA, Foghorn Therapeutics
Discovery & Development US 2025 We're heading to San Diego October 2-3 and bringing a team ready to talk First-Time-Right CMC for small molecules—from solid form to formulation and IND.Date: October 2-3Location: Sheraton San Di...
Clinical and Commercial Manufacturing We provide flexible and reliable OSD manufacturing services using versatile technologies to address your formulation challenges.
Amorphous Solid Dispersions Amorphous solid dispersions have been shown to alter the properties of an API, including solubility, dissolution, and bioavailability. A variety of polymers or additives are available, and screening i...
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the Drug Manufacturing ...
Formulation Development Instead of one-size-fits-all platforms, Crystal Pharmtech applies a "First-Time-Right" strategy for formulation development to accelerate your molecule to First in Human (FIH) studies and onward to commercialization in a cost-effective and time-saving way.